Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $1.53 Million - $1.98 Million
-194,283 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $193,829 - $235,463
-23,130 Reduced 10.64%
194,283 $1.89 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $11,028 - $12,877
-1,114 Reduced 0.51%
217,413 $2.16 Million
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $18,074 - $22,391
-1,748 Reduced 0.79%
218,527 $2.52 Million
Q4 2020

Feb 12, 2021

BUY
$8.61 - $11.04 $54,621 - $70,037
6,344 Added 2.97%
220,275 $2.11 Million
Q3 2020

Nov 12, 2020

BUY
$8.57 - $12.69 $47,092 - $69,731
5,495 Added 2.64%
213,931 $1.89 Million
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $345,197 - $557,757
42,512 Added 25.62%
208,436 $2.54 Million
Q1 2020

May 13, 2020

SELL
$6.69 - $13.45 $145,815 - $293,156
-21,796 Reduced 11.61%
165,924 $1.41 Million
Q3 2019

Nov 13, 2019

SELL
$6.16 - $9.6 $318,114 - $495,763
-51,642 Reduced 21.57%
187,720 $1.3 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $622,203 - $1.2 Million
-76,626 Reduced 24.25%
239,362 $2.17 Million
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $973,812 - $1.25 Million
-62,504 Reduced 16.51%
315,988 $4.92 Million
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $2.32 Million - $3.79 Million
158,862 Added 72.33%
378,492 $5.94 Million
Q3 2018

Nov 13, 2018

BUY
$21.06 - $25.65 $304,696 - $371,104
14,468 Added 7.05%
219,630 $4.67 Million
Q2 2018

Aug 13, 2018

SELL
$16.77 - $24.71 $251,550 - $370,650
-15,000 Reduced 6.81%
205,162 $4.99 Million
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $1.96 Million - $2.59 Million
-117,220 Reduced 34.74%
220,162 $3.75 Million
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $39,215 - $66,697
-3,492 Reduced 1.02%
337,382 $6.39 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $753,256 - $1.57 Million
48,881 Added 16.74%
340,874 $6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
291,993
291,993 $9.59 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.